Burleson & Company, LLC Medpace Holdings, Inc. Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 35 shares of MEDP stock, worth $14,383. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$14,383
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MEDP
# of Institutions
622Shares Held
25.1MCall Options Held
154KPut Options Held
117K-
Vanguard Group Inc Valley Forge, PA2.5MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY2.49MShares$1.02 Billion0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT974KShares$400 Million2.07% of portfolio
-
Invesco Ltd. Atlanta, GA816KShares$335 Million0.07% of portfolio
-
State Street Corp Boston, MA697KShares$286 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $12.8B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...